BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $30.57 million versus the consensus estimate of $25.54 million.

GUIDANCE:

BioLife Solutions sees FY2024 revenue of $98-100 million, versus the consensus of $110.6 million.

For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.